LENVATINIB

lenvatinib 10 mg capsule, 30

LENVATINIB (10965D)

lenvatinib 10 mg capsule, 30
10965D
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  17864

Indication: Locally advanced or metastatic differentiated thyroid cancer
Treatment phase: Initial treatment

Restriction  17865

Indication: Locally advanced or metastatic differentiated thyroid cancer
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 60 # of repeats: 2 DPMQ: $4,162.94 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Lenvima